Data on age, sex, body mass index (BMI), smoking history, physical activity limitations, occupation, EuroQoL five dimensions questionnaire (EQ-5D) index value, and spirometric results were obtained from the Korea NHANES database. Respiratory symptoms, including cough, sputum, and dyspnea, were measured qualitatively (presence or absence). To assess physical activity limitations, we used a questionnaire, “Do you experience physical activity limitations due to respiratory disease?”, and this was also measured qualitatively (yes or no).

The EQ-5D enables the respondent to classify his or her health according to five dimensions. These dimensions define health in terms of mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each dimension is divided into three levels, i.e., no problem/some or moderate problems/extreme problems. The information derived from the EQ-5D self-classifier can be converted into a single summary index: the EQ-5D index [13]. The EQ-5D index ranges between 0 (worst imaginable health state) and 1 (best imaginable health state).

Spirometry was performed according to the recommendations of the American Thoracic Society and European Respiratory Society [14]. Since post-bronchodilator spirometry was not available in Korea NHANES database, pre-bronchodilator spirometry results were used in our study. Absolute values of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were obtained, and the percentage of predicted values (% predicted) for FEV1 and FVC were calculated using the reference equation obtained on analysis of a representative Korean sample [15]. Comorbidities of asthma, diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease, osteoporosis, osteoarthritis or rheumatoid arthritis, and depression were self-reported based on previous physician diagnosis [16].

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.